SecBot SecBot
Insider Cluster (3 insiders) ·Filed Apr 30, 2026

EBS

Emergent BioSolutions Inc.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago
Insider cluster: 3 insiders, $0.4M total
Actionable Insight • Neutral

Insider selling is routine and not actionable. Monitor upcoming earnings for any fundamental changes, but no immediate trading signal from this cluster.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$8.23
T+0 close · Apr 29, 2026 · via day close
Latest settled
−10.94%
T+60 · $7.33
Vs SPY
−14.04%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 30 $8.23entry
  2. T+1 · 7mo ago +2.92%α +2.70% · $8.47
  3. T+5 · 6mo ago +10.57%α +8.84% · $9.10
  4. T+20 · 6mo ago +11.54%α +6.58% · $9.18
  5. T+60 · 4mo ago −10.94%α −14.04% · $7.33
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three directors of Emergent BioSolutions sold a total of approximately $385K in open-market shares over two days, representing less than 0.1% of market cap. This is routine insider selling, not indicative of material concerns, especially given concurrent non-cash stock grants to the same directors.

Key Financial Metrics

Direction
selling
Total Value
$385.0K
Insiders
3

Key Facts

  • 3 directors sold shares: Katkin Keith ($128K), DeGolyer Donald W ($121K), Zoon Kathryn C ($135K)
  • Total open-market sales: ~$385K, ~0.09% of $437M market cap
  • All sales occurred at ~$8.28-$8.36 per share on April 30 and May 1, 2026
  • Multiple directors also received non-cash stock grants (A) on April 30, 2026

Financial Impact

Total insider sales of $385K are trivial relative to $437M market cap

insider ownership

Risk Factors

  • Further insider selling if negative news emerges
  • No C-suite participation reduces signal

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-EBS-1777930260656

Track record

23 reports on EBS

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +14.89% at T+20 after the Apr 29, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $5.76 Now $5.81 +0.96% settles Nov 23
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.75 Now $5.81 +1.13% settles Nov 23
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.79 Now $5.81 +0.35% settles Nov 23
  4. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $5.85 to $5.89 Now $5.81 −0.68% ▲ +0.68% −2.61% vs SPY
  5. Nov 2, 202614d ago 8-K Bearish 6/10 Entry $6.25 to $6.05 Now $5.81 +7.04% ▲ +3.20% +2.61% vs SPY
  6. Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $6.81 to $6.06 Now $5.81 −14.68% ▼ −11.01% −8.31% vs SPY
  7. Oct 16, 20264w ago 8-K Neutral 3/10 Entry $6.38 to $6.23 Now $5.81 −8.93% ▼ −2.35% −2.44% vs SPY
  8. Oct 7, 20265w ago 144 Neutral 2/10 Entry $6.81 to $7.18 Now $5.81 −14.68% ▲ +5.43% +5.71% vs SPY
  9. Jun 29, 202620w ago 8-K Bullish 5/10 Entry $8.46 to $8.18 Now $5.81 −31.32% ▼ −3.31% −4.70% vs SPY
  10. Jun 4, 202623w ago Press Release Neutral 2/10 Entry $8.44 to $8.39 Now $5.81 −31.16% ▼ −0.59% +1.96% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026